National Account Director - Payers
Regeneron Pharmaceuticals
Summary
The National Account Director, Payers reports to the Executive Director, Payer Customer Engagement and leads all aspects of Regeneron's relationship with assigned national payer accounts, including strategic health plans and PBMs. You will develop key relationships with senior decision-makers and manage account development to achieve objectives for Regeneron's product portfolio across Ophthalmology, Neurology, Rare Disease, and Oncology, ensuring appropriate coverage, coding, and payment.
Job description
When & where
- Location: Remote - US
- Ability to travel up to 40%, including customer sites, industry meetings, and company locations.
Discover your role
- Lead all aspects of the Regeneron relationship with assigned national payer accounts, building trusted-partner relationships with senior decision-makers and using strong executive presence to present, negotiate, and elevate Regeneron's standing.
- Develop annual and long-term account plans aligned with corporate and brand goals, informed by each account's formulary, utilization management, and pipeline priorities, including launch readiness for new products and indications.
- Negotiate pricing and contract terms in line with brand access strategy and GTN goals, securing appropriate formulary placement and reimbursement across medical and pharmacy benefits.
- Lead the cross-functional team on commercial and Medicare RFPs, deal evaluations, and cases, and manage contract approval and execution with Legal and Contract Development.
- Monitor contract performance, rebate activity, and payment accuracy, track payer brand benchmarks, and provide input to sales and rebate forecasts.
- Partner with Regional Account Managers and field teams to complete access pull-through and drive adoption.
- Monitor payer trends, competitor activity, and policy changes (e.g., IRA, Part D redesign) to identify risks and opportunities, and update Commercial leadership regularly.
- Serve as the payer subject matter expert for Commercial and functional partners, and mentor Regional Account, field sales, and home office staff.
- Ensure all activities align with commercial, legal, regulatory, and pricing requirements (e.g., Medicaid best price).
Requirements
- Bachelor's degree from an accredited college or university
- 10+ years of progressively responsible industry experience
- 3+ years in national payer or managed markets account management with national plans, PBMs, or large regional entities
- Proven success negotiating managed markets contracts, including in difficult situations, and driving pull-through
- Demonstrated knowledge of payer decision-making and reimbursement processes (policy, coverage, coding, and patient access), with a focus on buy-and-bill, self-injectables, and specialty products
- Strong understanding of contract economics, including GTN, rebates, and forecasting
- Experience launching products with national payers
- Working knowledge of pricing and healthcare compliance requirements (e.g., Medicaid best price, Medicare Part B/D)
- Exceptional verbal, written, and presentation skills, with the ability to build relationships with key decision-makers
- Strong leadership, planning, organizational, and problem-solving skills, with the ability to work independently, meet deadlines, and manage multiple projects in a changing payer and corporate environment
- Proven ability to lead cross-functional teams without direct authority and to collaborate with commercial, field, and account teams to improve planning and pull-through
- Ability to travel up to 40%, including customer sites, industry meetings, and company locations
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life insurance
- Disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.